Travelling with children and adolescents with rheumatic diseases

被引:0
作者
Freudenhammer, M. [1 ,2 ]
Hufnagel, M. [1 ]
机构
[1] Univ Klinikum Freiburg, Abt Padiatr Infektiol & Rheumatol, Klin Allgemeine Kinder & Jugendmed, Mathildenstr 1, D-79106 Freiburg, Germany
[2] Univ Freiburg, Med Fak, IMM PACT Clinician Scientist Programm, Freiburg, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2021年 / 80卷 / 07期
关键词
Pediatric rheumatology; Immunosuppression; Travel medicine; Travel-related infectious diseases; Vaccination;
D O I
10.1007/s00393-021-01002-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Due to the underlying disease and immunosuppressive treatment, pediatric patients with rheumatic diseases are at increased risk for (long distance) travel-related health problems. A pretravel comprehensive consultation is therefore strongly recommended. Whether a child with rheumatic disease is sufficiently fit for travel essentially depends on the disease activity, the age of the child and the intended travel destination. Depending on the level of immunosuppression, the risks for this patient group include (travel-related) infections and the possibility of disease activity flares. Of particular importance is adequate exposure prevention: standard vaccinations should be updated and indications for travel vaccinations evaluated in advance of travelling. In this context, potential contraindications, especially for live vaccines, in the case of specific immunosuppressive treatment should be considered. In the event of travel to malaria endemic areas, the necessity for chemoprophylaxis or stand-by medication must be evaluated but caution is needed regarding potential drug interactions. Detailed education about careful hand, food and contact hygiene is critical. Because photosensitivity may be increased in some rheumatic diseases and/or medications, UV protection is crucial. Barriers (clothes and mosquito nets) and age-appropriate chemical insect repellents should be used to prevent insect-borne diseases. Before start of travel, possibilities for on-site medical help in the event of disease deterioration and/or infection should be evaluated. This should be included in the assessment of the patient's ability to travel. Travelers with rheumatic disease should carry a first aid kit that includes both a sufficient supply of regular antirheumatic medication and supplemental medication in case of a disease flare. Storage conditions must be taken into account for some medications. Ultimately, the success of a journey depends on the planning from the perspective of the child with its specific needs.
引用
收藏
页码:620 / 628
页数:9
相关论文
共 37 条
  • [1] Ultraviolet radiation and systemic lupus erythematosus
    Barbhaiya, M.
    Costenbader, K. H.
    [J]. LUPUS, 2014, 23 (06) : 588 - 595
  • [2] The emerging problem of biological treatment in migrant and travelling populations: it is time to extend guidelines for the screening of infectious diseases
    Bartalesi, F.
    Bartoloni, A.
    Bisoffi, Z.
    Spinicci, M.
    Gimenez Sanchez, F.
    Munoz, J.
    Richi, P.
    Minisola, G.
    Munoz-Fernandez, S.
    Matucci-Cerinic, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (05) : 794 - 796
  • [3] Brief Report: Incidence of Selected Opportunistic Infections Among Children With Juvenile Idiopathic Arthritis
    Beukelman, Timothy
    Xie, Fenglong
    Baddley, John W.
    Chen, Lang
    Delzell, Elizabeth
    Grijalva, Carlos G.
    Mannion, Melissa L.
    Patkar, Nivedita M.
    Saag, Kenneth G.
    Winthrop, Kevin L.
    Curtis, Jeffrey R.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (05): : 1384 - 1389
  • [4] Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment
    Beukelman, Timothy
    Xie, Fenglong
    Chen, Lang
    Baddley, John W.
    Delzell, Elizabeth
    Grijalva, Carlos G.
    Lewis, James D.
    Ouellet-Hellstrom, Rita
    Patkar, Nivedita M.
    Saag, Kenneth G.
    Winthrop, Kevin L.
    Curtis, Jeffrey R.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (08): : 2773 - 2780
  • [5] Committee to Advise on Tropical Medicine and Travel (CATMAT), 2012, CAN COMMUN DIS REP, V38, P1, DOI [10.14745/ccdr.v38i00a03, DOI 10.14745/CCDR.V38I00A03]
  • [6] Yellow fever vaccination for immunocompromised travellers: unjustified vaccination hesitancy?
    de Jong, Wesley
    de Man, Rob A.
    Dalm, Virgil A. S. H.
    Reusken, Chantal B. E. M.
    Goeijenbier, Marco
    van Gorp, Eric C. M.
    [J]. JOURNAL OF TRAVEL MEDICINE, 2019, 26 (06)
  • [7] Travel-related health risks in moderately and severely immunocompromised patients: a case-control study
    Dekkiche, Souad
    de Valliere, Serge
    D'Acremont, Valerie
    Genton, Blaise
    [J]. JOURNAL OF TRAVEL MEDICINE, 2016, 23 (03)
  • [8] Pre-Travel Health Preparation of Pediatric International Travelers: Analysis From the Global TravEpiNet Consortium
    Hagmann, Stefan
    LaRocque, Regina C.
    Rao, Sowmya R.
    Jentes, Emily S.
    Sotir, Mark J.
    Brunette, Gary
    Ryan, Edward T.
    [J]. JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2013, 2 (04) : 327 - 334
  • [9] Illness in Children After International Travel: Analysis From the GeoSentinel Surveillance Network
    Hagmann, Stefan
    Neugebauer, Richard
    Schwartz, Eli
    Perret, Cecilia
    Castelli, Francesco
    Barnett, Elizabeth D.
    Stauffer, William M.
    [J]. PEDIATRICS, 2010, 125 (05) : E1072 - E1080
  • [10] Travel and biologic therapy: travel-related infection risk, vaccine response and recommendations
    Hall, Victoria
    Johnson, Douglas
    Torresi, Joseph
    [J]. JOURNAL OF TRAVEL MEDICINE, 2018, 25